EP Patent

EP2682387A2 — C7-fluoro substituted tetracycline compounds

Assigned to Tetraphase Pharmaceuticals Inc · Expires 2014-01-08 · 12y expired

What this patent protects

The present invention is directed to a compound falling under Structural Formula (A): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (A) are defined herein. Also described is a pharmaceutical composition comprising the compound of Struct…

USPTO Abstract

The present invention is directed to a compound falling under Structural Formula (A): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (A) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (A) and its therapeutic use.

Drugs covered by this patent

Patent Metadata

Patent number
EP2682387A2
Jurisdiction
EP
Classification
—
Expires
2014-01-08
Drug substance claim
No
Drug product claim
No
Assignee
Tetraphase Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.